Qube Research & Technologies (QRT)
CALC icon

Qube Research & Technologies (QRT)’s CalciMedica CALC Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$4 – 3374
2024
Q2 		$4 Sell
1
-1,228
-100% -$6.19K ﹤0.01% 3656
2024
Q1 		$5.11K Buy
1,229
+1,228
+122,800% +$5.61K ﹤0.01% 3892
2023
Q4 		$3 Hold
1
– – ﹤0.01% 4226
2023
Q3 		$3 Buy
+1
New +$3 ﹤0.01% 3984

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CALC Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of CalciMedica (CALC) in Q3 2024, closing a stake of 1 share — an estimated $4 sold.

Qube Research & Technologies (QRT) first reported a position in CALC in Q3 2023 and held it in 4 quarters. The position peaked at $5.11K in Q1 2024. 24 funds tracked by Wall St. Rank hold CALC as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining CalciMedica position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1 CalciMedica share in Q3 2024, an estimated $4.
  • Qube Research & Technologies (QRT) first reported a position in CalciMedica in Q3 2023 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s CalciMedica position peaked at $5.11K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held CalciMedica as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.